Home/Filings/4/0000950170-24-026997
4//SEC Filing

Schatzman Randall C 4

Accession 0000950170-24-026997

CIK 0001641281other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 1:28 PM ET

Size

5.4 KB

Accession

0000950170-24-026997

Insider Transaction Report

Form 4
Period: 2024-03-04
Schatzman Randall C
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-04+654,000235,000 total
    Exercise: $1.27Exp: 2034-03-03Common Stock (654,000 underlying)
Footnotes (1)
  • [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.

Documents

1 file

Issuer

Bolt Biotherapeutics, Inc.

CIK 0001641281

Entity typeother

Related Parties

1
  • filerCIK 0001604763

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 1:28 PM ET
Size
5.4 KB